|
CMPA to net Rx writers: you're
on your own
Everyone's tied in a knot over
cross-border web scripts except the companies selling
the product -- and the docs writing the slips with both
hands
By Robb Beattie
Providing cheaper Canadian drugs
to American patients has grown into a billion-dollar
business. At the same time, the doctors who sign Internet
prescriptions at $15 a pop are increasingly isolated.
A National Review of Medicine poll conducted
last December showed that fully 91% of physicians considered
the practice either "unacceptable" or "borderline."
In February, the Canadian Medical Protective Association
(CMPA), which provides malpractice coverage to virtually
all practising physicians in the country said it would
no longer represent physicians who were sued by an American
patient for whom they'd signed an Internet prescription.
"I don't know if our statement
will stop doctors from engaging in the practice," says
Dr John Gray, Executive Director of the CMPA. "We've
been issuing progressively more pointed warnings over
the last two years, first telling doctors that it put
them at risk of being sued or investigated by their
college. Then last year we said we might not assist
if they encountered medical-legal difficulty. And now,
we've stated we categorically will not assist, whether
the legal action is brought against the physician in
the US or Canada."
The CMPA's latest position was
taken on the basis of provincial college rulings that
prescribing over the Internet without seeing a patient
does not meet the standard of care. "The colleges have
defined very clearly what is an appropriate circumstance
for physicians to renew or cosign a prescription for
a patient, and what isn't," states Dr Gray. "When a
snowbird asks for a prescription to be renewed by a
Canadian doctor with whom they have an existing relationship,
that's acceptable.... Similarly, the colleges deem it
acceptable for a physician to renew a prescription for
a patient who isn't their own personal patient, but
part of their call group."
The conditions that must be present
in order for a doctor to issue a prescription include
knowledge of the patient's condition, examination, opportunity
for follow-up and for questions to be asked. Clearly
with Internet prescribing, these conditions can't be
met.
EXPONENTIAL
GROWTH
Despite objections from medical and pharmacy associations
-- and polls that show that Canadian doctors are overwhelmingly
opposed to the practice, Dr Gray says the number of
prescriptions issued in Canada for US patients is growing
exponentially. Just how many doctors are signing these
prescriptions remains somewhat mysterious. A handful
have been sanctioned by their provincial college but
to date no licenses have been revoked and no lawsuits
have yet been reported by the CMPA -- it cannot comment
on open cases and most take three to four years to close.
Dr Durhane Wong-Rieger, Chair of
the Consumer Advocare Network and President of the Anemia
Institute, doesn't believe that the medical associations
and colleges can curb Internet prescribing without the
government actively behind them. "Unfortunately, government
is looking at the revenue side of the equation," says
Dr Wong-Rieger, "and is not looking for effective ways
to stop it. They were far more effective when it came
to stopping the re-importation of cigarettes." She worries
about the threat Internet prescribing poses to the supply
of drugs in Canada. "A number of major US-based drug
companies have already limited their shipments to Canadian
pharmacies to what they view as Canadian need," she
says. She even goes so far as to suggest that companies
"will not tolerate Canadian pricing practices if the
situation continues."
More serious, perhaps, is that
supply pressure is also encouraging Internet pharmacies
to purchase drugs from countries which do not have mutual
recognition agreements with either Canada or the US
for pharmaceutical good manufacturing processes. "If
these drugs are making their way into Canada and on
to the US, there's nothing stopping them from being
sold in Canada as well," says Dr Wong-Rieger. "Government
has already said it doesn't have the resources to conduct
on-the-ground inspections of pharmacy drugs." She cites
a recent FDA report finding that 80% of the drugs they
intercepted en route to American patients were from
Canadian pharmacies and more than 50% of these drugs
were not what they were labelled to be.
She speaks regularly to American
mayors and state governors on the issue and says they
recognize that their professed interest in buying drugs
from Canada is little more than a political ploy to
deal with drug costs and get Washington to provide better
coverage for their citizens.
|